ETFs & Funds
really a bit of a dog in disguise ?? never seems able to rise above 4 dollars without getting whacked
It's not a disguse. Michael West is brilliant and all, but in 20+ years with three co's, he hasn't brought a single drug into an FDA trial.
well the last meaningful thing I heard was that BTX great science is falling behind other companies moving ahead in the race
Add a reply...
Latest StockTalks »
people get BTX breaking news and analysis by email alert.
Get email alerts on BTX »
Get latest price
From other sites
Asterias Biotherapeutics Announces Public Offering of Common Stock
at Benzinga.com (Feb 4, 2015)
The other 'rotation' keeps stocks spinning
at CNBC.com (Apr 8, 2014)
BioTime Reports Isolation of Novel Brain-Associated Cells From Human Embryonic Stem Cells
at CNBC.com (Dec 20, 2013)
Biotech Report: Are stem-cell stocks a good buy?
at MarketWatch.com (Jul 13, 2011)